Tonix Pharmaceuticals is conducting the OASIS study at the University of North Carolina, where Sina Bavari serves as Executive Vice President of Infectious Disease Research and Development.
1 report, 0 independent
Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tonix Pharmaceuticals is conducting the OASIS study at the University of North Carolina, where Sina Bavari serves as Executive Vice President of Infectious Disease Research and Development.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tonix Pharmaceuticals
commercial pharmaceutical company
-
University of North Carolina
public university system for North Carolina, USA
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet